Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin.
| Image |  |
|---|---|
| Description | scientific article published on 8 April 2009 |
| Author/s |
author: David Sheridan |
| Publication date | April 8, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |